Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis
Volume: 98, Issue: 10, Pages: 1448 - 1452
Published: Jul 17, 2014
Abstract
Background/aim
Anti-VEGF treatment is the therapy of choice in age-related macular degeneration, and is also applied in diabetic macular oedema or retinal vein occlusion. Recently, the fusion protein, aflibercept, has been approved for therapeutic use. In this study, we investigate the effects of aflibercept on primary RPE cells.Methods
Primary RPE cells were prepared from freshly slaughtered pigs’ eyes. The impact of...Paper Details
Title
Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis
Published Date
Jul 17, 2014
Volume
98
Issue
10
Pages
1448 - 1452
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History